Polynovo (ASX:PNV) — Material Events

ASX:PNV · 10 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major 1 article Significant 8 articles Notable 1 article Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
8
PolyNovo Accelerates Growth with 26% Sales Surge and New Manufacturing CapacityMedium
PolyNovo posts 26% sales growth in 1H FY26 with strong U.S. expansion and positive cash flow
19 Jan 2026 ·Trading Update ·85
PolyNovo’s Revenue Surges 25% Amid R&D Setbacks and FDA PrepMedium
PolyNovo H1 FY26 revenue up 25%, profit near breakeven due to R&D fire and FDA prep
20 Feb 2026 ·Half-Year Financial Report ·85
PolyNovo Surges with 29% Sales Growth and A$33.5m Cash Boost in FY25Medium
PolyNovo posts strong FY25 results with 29% sales growth, cash up to A$33.5m, and expanding global footprint
29 July 2025 ·Trading Update ·85
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.

Market Mentions 4 - appeared in market wrap coverage